Hoba Therapeutics ApS: Financial statements 2026
CVR: 38231170
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899. The solvency ratio was 7.3%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -61,710,701
- Profit/Loss
- DKK -67,693,868
- Equity
- DKK 1,143,899
- Total Assets
- DKK 15,583,219
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | -61.7M | -67.7M | 1.1M | 7 |
| 2025 | - | -38.3M | -43M | 26.1M | 8 |
| 2024 | - | -20.9M | -27.8M | 69.1M | 8 |
| 2023 | - | -9.4M | -13.9M | -32.9M | 6 |
| 2022 | 0 | -7.2M | -10.9M | -19M | 3 |
Official annual report
Find more companies like Hoba Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Contact info changed: new email: [email protected], new website: www.hobatherapeutics.com (October 8, 2026).
Contact info changed: new email: [email protected], new website: www.hobatherapeutics.com (June 3, 2026).
As of June 1, 2026, Gonçalo Nuno Nunes da Silva Rebelo de Andrade has joined the board of directors of Hoba Therapeutics ApS.
As of May 31, 2026, Gonçalo Nuno Nunes da Silva Rebelo de Andrade has left the board of directors of Hoba Therapeutics ApS.
As of May 31, 2026, Jean Marcel André Combalbert has left the board of directors of Hoba Therapeutics ApS.
Address changed to Nordre Fasanvej 215, 2000 Frederiksberg (May 13, 2026).
Contact info changed: new email: [email protected], new website: www.hobatherapeutics.com (May 13, 2026).
Contact info changed: new email: [email protected], new website: www.hobatherapeutics.com (April 14, 2026).
As of April 8, 2026, Camilla Petrycer Hansen has left the board of directors of Hoba Therapeutics ApS.
As of April 8, 2026, Kuang He has left the board of directors of Hoba Therapeutics ApS.
About Hoba Therapeutics ApS
Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.
